Evaluation of Total Homocysteine Levels in Relation to Abdominal Fat Mass and Traditional Cardiovascular Risk Factors in Overweight and Obese Adolescents
- PMID: 40868976
- PMCID: PMC12387805
- DOI: 10.3390/life15081329
Evaluation of Total Homocysteine Levels in Relation to Abdominal Fat Mass and Traditional Cardiovascular Risk Factors in Overweight and Obese Adolescents
Abstract
Cardiovascular diseases remain the leading cause of mortality worldwide, with multiple risk factors contributing to their development. Among these, obesity and hyperhomocysteinemia have been recognized as significant contributors to endothelial dysfunction, a key early event in the pathogenesis of atherosclerosis. Our study aimed to evaluate the relationship between total homocysteine (tHcy) levels and traditional cardiovascular risk factors in overweight and obese adolescents. We enrolled 42 obese, 14 overweight, and 25 non-obese children. No significant differences in tHcy levels were observed between overweight, obese, and non-obese adolescents. Homocysteine positively correlated with age (r = 0.433, p < 0.011) and creatinine concentrations (r = 0.363, p = 0.001) in the overall group of overweight, obese, and non-obese children, as well as in the combined group of overweight and obese children (for age: r = 0.275, p = 0.025; for creatinine: r = 0.278, p = 0.025). We did not find any association between homocysteine and atherogenic lipid profile, insulin-resistance status, blood pressure, and inflammatory parameters in overweight and obese patients. Age emerged as the strongest independent predictor of homocysteine levels. The observed association with creatine suggests a potential renal contribution to homocysteine metabolism.
Keywords: adolescents; cardiovascular risk factors; homocysteine; obesity.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Hormonal contraceptives for contraception in overweight or obese women.Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4. Cochrane Database Syst Rev. 2016. PMID: 27537097 Free PMC article.
-
Lifestyle intervention for improving school achievement in overweight or obese children and adolescents.Cochrane Database Syst Rev. 2014 Mar 14;(3):CD009728. doi: 10.1002/14651858.CD009728.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2018 Jan 29;1:CD009728. doi: 10.1002/14651858.CD009728.pub3. PMID: 24627300 Updated.
-
Gut microbiome-based interventions for the management of obesity in children and adolescents aged up to 19 years.Cochrane Database Syst Rev. 2025 Jul 10;7(7):CD015875. doi: 10.1002/14651858.CD015875. Cochrane Database Syst Rev. 2025. PMID: 40637175 Review.
-
Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD012513. doi: 10.1002/14651858.CD012513.pub3. Cochrane Database Syst Rev. 2023. PMID: 36971688 Free PMC article.
-
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2. Cochrane Database Syst Rev. 2018. PMID: 30039871 Free PMC article.
References
-
- Koklesova L., Mazurakova A., Samec M., Biringer K., Samuel S.M., Büsselberg D., Kubatka P., Golubnitschaja O. Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person. EPMA J. 2021;12:477–505. doi: 10.1007/s13167-021-00263-0. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources